Pan F - Search Results

1

Lipid-Based Nanocarriers Enabled Oral Delivery of Oleanolic Acid Derivative DKS26 for Diabetes Management.

Ban Y, Chu Y, Pan F, Guo Z, Yang Y, Wei X, Li G, Qian J, Zhan C, Zhang J, Tang L. Ban Y, et al. Among authors: pan f. Adv Healthc Mater. 2023 Jun;12(16):e2300639. doi: 10.1002/adhm.202300639. Epub 2023 Apr 25. Adv Healthc Mater. 2023. PMID: 36977335

2

cRGD enables rapid phagocytosis of liposomal vancomycin for intracellular bacterial clearance.

Li G, Wang M, Ding T, Wang J, Chen T, Shao Q, Jiang K, Wang L, Yu Y, Pan F, Wang B, Wei X, Qian J, Zhan C. Li G, et al. Among authors: pan f. J Control Release. 2022 Apr;344:202-213. doi: 10.1016/j.jconrel.2022.02.030. Epub 2022 Feb 27. J Control Release. 2022. PMID: 35235809

3

Protein corona mediated liposomal drug delivery for bacterial infection management.

Shao Q, Ding T, Pan F, Li G, Shen S, Qian J, Zhan C, Wei X. Shao Q, et al. Among authors: pan f. Asian J Pharm Sci. 2022 Nov;17(6):855-866. doi: 10.1016/j.ajps.2022.10.003. Epub 2022 Nov 5. Asian J Pharm Sci. 2022. PMID: 36600900 Free PMC article.

4

Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin.

Yu YF, Wu EC, Lin SQ, Chu YX, Yang Y, Pan F, Ding TH, Qian J, Jiang K, Zhan CY. Yu YF, et al. Among authors: pan f. Acta Pharmacol Sin. 2024 Mar;45(3):646-659. doi: 10.1038/s41401-023-01169-5. Epub 2023 Oct 16. Acta Pharmacol Sin. 2024. PMID: 37845342

5

Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines.

Yang M, Zhang Z, Jin P, Jiang K, Xu Y, Pan F, Tian K, Yuan Z, Liu XE, Fu J, Wang B, Yan H, Zhan C, Zhang Z. Yang M, et al. Among authors: pan f. Int J Pharm. 2024 Jan 25;650:123695. doi: 10.1016/j.ijpharm.2023.123695. Epub 2023 Dec 9. Int J Pharm. 2024. PMID: 38081560

6

Phospholipid Type Regulates Protein Corona Composition and In Vivo Performance of Lipid Nanodiscs.

Pan F, Liu M, Li G, Chen B, Chu Y, Yang Y, Wu E, Yu Y, Lin S, Ding T, Wei X, Zhan C, Qian J. Pan F, et al. Mol Pharm. 2024 May 6;21(5):2272-2283. doi: 10.1021/acs.molpharmaceut.3c01084. Epub 2024 Apr 12. Mol Pharm. 2024. PMID: 38607681

7

Effects of Surface IR783 Density on the In Vivo Behavior and Imaging Performance of Liposomes.

Long Q, Zhao X, Gao L, Liu M, Pan F, Gao X, Zhan C, Chen Y, Wang J, Qian J. Long Q, et al. Among authors: pan f. Pharmaceutics. 2024 May 30;16(6):744. doi: 10.3390/pharmaceutics16060744. Pharmaceutics. 2024. PMID: 38931866 Free PMC article.

8

Effects of drug-induced liver injury on the in vivo fate of liposomes.

Liu M, Wu E, Pan F, Tian K, Fu J, Yu Y, Guo Z, Ma Y, Wei A, Yu X, Zhan C, Qian J. Liu M, et al. Among authors: pan f. Eur J Pharm Biopharm. 2024 Aug;201:114389. doi: 10.1016/j.ejpb.2024.114389. Epub 2024 Jun 28. Eur J Pharm Biopharm. 2024. PMID: 38945407

9

Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin.

Jiang K, Tian K, Yu Y, Wu E, Yang M, Pan F, Qian J, Zhan C. Jiang K, et al. Among authors: pan f. Nat Commun. 2024 Jul 20;15(1):6136. doi: 10.1038/s41467-024-50568-7. Nat Commun. 2024. PMID: 39033145 Free PMC article.

10

Exemplifying interspecies variation of liposome in vivo fate by the effects of anti-PEG antibodies.

Wu E, Guan J, Yu Y, Lin S, Ding T, Chu Y, Pan F, Liu M, Yang Y, Zhang Z, Zhang J, Zhan C, Qian J. Wu E, et al. Among authors: pan f. Acta Pharm Sin B. 2024 Nov;14(11):4994-5007. doi: 10.1016/j.apsb.2024.07.009. Epub 2024 Aug 5. Acta Pharm Sin B. 2024. PMID: 39664439 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,163 results

Search Page

Filters